ETFB

Electron transfer flavoprotein subunit beta · P38117 · ETFB on Sugi Atlas →

453 patent compounds predicted against ETFB, 312 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours
Crenolanib Crenolanib (SCHEMBL2730601) 1.00 1/20
Crenolanib Crenolanib (SCHEMBL29350134) 1.00 1/20
Crenolanib Crenolanib (SCHEMBL29352568) 1.00 1/20
Crenolanib Crenolanib (SCHEMBL30002138) 1.00 1/20
SCHEMBL22567082 SCHEMBL22567082 0.86 1/20
SCHEMBL5662568 SCHEMBL5662568 0.85 1/20
Crenolanib Crenolanib (SCHEMBL4681285) 0.85 1/20
Crenolanib Crenolanib (SCHEMBL29352554) 0.85 1/20
Crenolanib Crenolanib (SCHEMBL29361948) 0.85 1/20
SCHEMBL27030604 SCHEMBL27030604 0.85 1/20
SCHEMBL30775111 SCHEMBL30775111 0.85 1/20
SCHEMBL23026363 SCHEMBL23026363 0.82 1/20
SCHEMBL3191766 SCHEMBL3191766 0.80 1/20
SCHEMBL27030775 SCHEMBL27030775 0.80 1/20
SCHEMBL30441378 SCHEMBL30441378 0.80 1/20
SCHEMBL3180117 SCHEMBL3180117 0.79 1/20
SCHEMBL3189249 SCHEMBL3189249 0.78 1/20
SCHEMBL3190082 SCHEMBL3190082 0.78 1/20
SCHEMBL3190135 SCHEMBL3190135 0.78 1/20
SCHEMBL3182258 SCHEMBL3182258 0.76 1/20

Clinical trials — most relevant to ETFB by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Clinical Evaluation of the Effect of Metformin in Sepsis PHASE3UNKNOWN
A Study of Efficacy, Safety and Tolerability of Idebenone in the Treatment of Friedreich's Ataxia (FRDA) Patients PHASE3COMPLETED
Effect of Pioglitazone Administered to Patients With Friedreich's Ataxia: Proof of Concept PHASE3COMPLETED
Effect of Bezafibrate on Muscle Metabolism in Patients With Fatty Acid Oxidation Defects PHASE2COMPLETED
A Study of Bezafibrate in Mitochondrial Myopathy PHASE2COMPLETED
Metabolic Cofactor Supplementation in Obese Patients With Non-Alcoholic Fatty Liver Disease PHASE2COMPLETED
Metabolic Cofactor Supplementation in Alzheimer's Disease (AD) and Parkinson's Disease (PD) Patients PHASE2COMPLETED
Testing the Combination of MLN4924 (Pevonedistat), Carboplatin, and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) Who Have Previously Been Treated With Immunotherapy PHASE2ACTIVE_NOT_RECRUITING
Mitochondrial Dysfunction in the Pathophysiology and Treatment of Bipolar Disorder PHASE2WITHDRAWN
Melatonin in Healthy Volunteers PHASE1COMPLETED
NCF Gene & TNFSF4 in SLE Patients nanUNKNOWN
Apoptosis Markers in Aggressive Periodontitis nanCOMPLETED
Transcranial Photobiomodulation for the Treatment of Pediatric Depression nanWITHDRAWN
Pathogenesis of Acute Stress Induced (Tako-tsubo) Cardiomyopathy: Energy Shut-Down or Intense Inflammation? nanCOMPLETED
Relationship Between Mitochondrial Dysfunction and Fatique in Cancer Patients Following External Beam Radiation Therapy nanCOMPLETED
Mitoquines in COPD nanUNKNOWN
Resistance Exercise in Barth Syndrome nanCOMPLETED
Exercise-mediated Rescue of Mitochondrial Dysfunctions Driving Insulin Resistance nanCOMPLETED
Physical Activity Following Surgery Induced Weight Loss nanCOMPLETED
Effect Inhaled Nitric Oxide in Adult Liver Transplant nanNOT_YET_RECRUITING
Mild Intermittent Hypoxia and Its Multipronged Effect on Sleep Apnea nanRECRUITING
TranspulmonarY Estrogen Gradient and Estrogen Receptors (TYEGER) in PAH nanWITHDRAWN
Effect of Subtle Energy Transmission and Tao Calligraphy Mindfulness Practice on Mitochondrial DNA in Peripheral Blood Leukocytes nanNOT_YET_RECRUITING
Mitochondrial Function of Immune Cells in Sepsis nanCOMPLETED
Tissue Sample Study for Mitochondrial Disorders nanENROLLING_BY_INVITATION
Nutraceutical Composition Containing Natural Products Derivatives on the Modulation of the Endocrine Neuroimmune Axis nanCOMPLETED
Natural History Study of FDXR Mutation-related Mitochondriopathy nanCOMPLETED
Fatty Acid Metabolism and Insulin Sensitivity: the Role of Endurance Exercise nanCOMPLETED
Fatty Acid Oxidation Defects and Insulin Sensitivity nanCOMPLETED
Parkinson's Diseases Susceptibility Genes and Pesticides nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a ETFB binder may also engage these)

ProteinNameSimilarity
Q68FU3 1.000 Q68FU3 →
Q9DCW4 1.000 Q9DCW4 →
Q6UAQ8 1.000 Q6UAQ8 →
Q5RFK0 1.000 Q5RFK0 →
Q2TBV3 0.999 Q2TBV3 →
P38975 0.999 P38975 →
P53575 0.998 P53575 →
Q9LSW8 0.995 Q9LSW8 →
Q54YZ4 0.995 Q54YZ4 →
Q9UTH2 0.990 Q9UTH2 →
P42940 0.989 P42940 →
A2XQV4 0.988 A2XQV4 →
P53576 0.988 P53576 →
Q7F9U3 0.987 Q7F9U3 →
P26482 0.987 P26482 →
O33095 0.986 O33095 →
Q57770 0.985 Q57770 →
H6LBB0 0.984 H6LBB0 →
Q9V2T8 0.984 Q9V2T8 →
O29871 0.983 O29871 →
A8MAJ1 0.983 A8MAJ1 →
P97089 0.983 P97089 →
P28488 0.983 P28488 →
Q7NUC2 0.983 Q7NUC2 →
Q8PV87 0.983 Q8PV87 →
A3DKB6 0.983 A3DKB6 →
Q9C4Z0 0.982 Q9C4Z0 →
Q0AZ34 0.982 Q0AZ34 →
A7I6S6 0.982 A7I6S6 →
A1AZH7 0.982 A1AZH7 →